|
|
|
|
|
by wallaBBB
1659 days ago
|
|
This is the second attempt of this kind at tackling aging of the lens by Novartis (formerly Alcon).
Unfortunately previous drug (some 10ish years ago) got pulled off the market after studies couldn't confirm the claims - basically it did nothing. Hopefully this time it works, because this is the only real solution, and not pupil size manipulation. |
|